Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 55601 - 55625 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▼ Gene Name UniProt ID
C0242383 Age related macular degeneration CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0006142 Malignant neoplasm of breast CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0024623 Malignant neoplasm of stomach CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C1837218 Cleft palate, isolated CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C4721610 Carcinoma, Ovarian Epithelial CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0023903 Liver neoplasms CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0678222 Breast Carcinoma CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0036341 Schizophrenia CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0242379 Malignant neoplasm of lung CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0040128 Thyroid Diseases CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C2239176 Liver carcinoma CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C1306459 Primary malignant neoplasm CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0027765 nervous system disorder CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C1510586 Autism Spectrum Disorders CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0686347 Tardive Dyskinesia CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0003873 Rheumatoid Arthritis CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0015696 Fatty Liver, Alcoholic CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C1527303 Chronic Airflow Obstruction CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0006826 Malignant Neoplasms CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0002736 Amyotrophic Lateral Sclerosis CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0020538 Hypertensive disease CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0376358 Malignant neoplasm of prostate CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C1140680 Malignant neoplasm of ovary CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0346647 Malignant neoplasm of pancreas CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
C0030567 Parkinson Disease CYP1A2 1544 cytochrome P450 family 1 subfamily A member 2 P05177
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024